[Histological diagnostics in joint pathology due to increasing regenerative therapeutic strategies - special consideration for cartilage damage].

Histologische Diagnostik in der Gelenkpathologie in Zeiten rekonstruktiver Therapieverfahren – besondere Berücksichtigung der Knorpelschäden.

Journal

Der Pathologe
ISSN: 1432-1963
Titre abrégé: Pathologe
Pays: Germany
ID NLM: 8006541

Informations de publication

Date de publication:
May 2020
Historique:
pubmed: 28 3 2020
medline: 4 9 2020
entrez: 28 3 2020
Statut: ppublish

Résumé

Orthopedic and trauma surgery are currently confronted with significant changes in their interventional and therapeutic strategies, especially in knee surgery. Minimally invasive and reconstructive techniques lead not only to modifications of the repertoire of interventional methods but also of the indications and questions for histopathological diagnostics. The classical problems in knee surgery remain important issues, which are traumatic, degenerative, and infectious lesions. In addition, questions regarding regeneration and integration of cell-material constructs will become more and more important in the future. Furthermore, questions regarding the regenerative potential of an implantation site for such constructs and the morphological quality of harvested tissue for the in vitro cell expansion of autologous cells are becoming increasingly important. The autologous chondrocyte transplantation is a good example of the relevance of the histopathological re-evaluation of the regenerated tissue for a better understanding of the pathophysiology of reconstructive therapies. It becomes clear that for specific aims based on reconstructive therapies, new scoring systems should be established for the histopathological routine diagnostic service. Furthermore, there is need for the definition of further histopathological criteria, which will help to optimize the differential application of reconstructive strategies via tissue engineering. The present report gives a short overview of the modifying requirements on the histopathological diagnostics in specimens from knee-surgery but does not claim to be exhaustive.

Identifiants

pubmed: 32215684
doi: 10.1007/s00292-020-00768-x
pii: 10.1007/s00292-020-00768-x
doi:

Types de publication

Journal Article

Langues

ger

Sous-ensembles de citation

IM

Pagination

271-280

Références

Arthroscopy. 2014 Jan;30(1):80-5
pubmed: 24210971
N Engl J Med. 1994 Oct 6;331(14):889-95
pubmed: 8078550
Osteoarthritis Cartilage. 2016 Feb;24(2):270-3
pubmed: 26318660
Osteoarthritis Cartilage. 2006 Jan;14(1):13-29
pubmed: 16242352
J Orthop Res. 2016 Jan;34(1):135-40
pubmed: 26250350
J Bone Joint Surg Am. 2012 Sep 19;94(18):1700-11
pubmed: 22992880
Am J Sports Med. 2010 May;38(5):880-90
pubmed: 20203290
Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3228-37
pubmed: 24993568
Orthopade. 2017 Oct;46(10):822-830
pubmed: 28852795
Eur J Radiol. 2004 Dec;52(3):310-9
pubmed: 15544911
Knee Surg Sports Traumatol Arthrosc. 2018 Feb;26(2):589-595
pubmed: 28741153
Z Rheumatol. 2010 Sep;69(7):644-52
pubmed: 20213088
Am J Sports Med. 2011 Nov;39(11):2476-83
pubmed: 21515806
Osteoarthritis Cartilage. 2016 Nov;24(11):1918-1927
pubmed: 27349462
Knee Surg Sports Traumatol Arthrosc. 2013 Jul;21(7):1569-76
pubmed: 22829330
J Knee Surg. 2014 Dec;27(6):435-42
pubmed: 25172967
Injury. 2008 Apr;39 Suppl 1:S40-9
pubmed: 18313471
Pathologe. 2004 Sep;25(5):375-84
pubmed: 15257415
Knee. 2010 Jun;17(3):224-9
pubmed: 19800801
J Bone Joint Surg Am. 1971 Apr;53(3):523-37
pubmed: 5580011
Pathol Res Pract. 2017 Aug;213(8):874-881
pubmed: 28687159
Orthop Traumatol Surg Res. 2017 Jun;103(4):609-614
pubmed: 28373139
Dtsch Arztebl Int. 2018 Apr 20;115(16):269-275
pubmed: 29739493
Orthopade. 2017 Mar;46(3):234-241
pubmed: 28004128
Pathol Res Pract. 2014 Dec;210(12):779-86
pubmed: 25454771
J Biomed Mater Res B Appl Biomater. 2005 Aug;74(2):808-16
pubmed: 15981176
Pathologe. 2011 May;32(3):220-7
pubmed: 21505874
Curr Stem Cell Res Ther. 2014;10(1):43-55
pubmed: 25012737
J Cell Physiol. 2018 Feb;233(2):1342-1358
pubmed: 28513840
Pathologe. 2014 Nov;35 Suppl 2:264-70
pubmed: 25394976

Auteurs

Christoph Brochhausen (C)

Institut für Pathologie, Universität Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland. christoph.brochhausen@ukr.de.
Zentrum für Rheumapathologie GmbH, Mainz, Deutschland. christoph.brochhausen@ukr.de.

David Grevenstein (D)

Klinik und Poliklinik für Orthopädie und Unfallchirurgie, Uniklinik Köln, Köln, Deutschland.

Andreas Mamilos (A)

Institut für Pathologie, Universität Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland.

Maximilian Babel (M)

Zentrum für Rheumapathologie GmbH, Mainz, Deutschland.

Peer Eysel (P)

Klinik und Poliklinik für Orthopädie und Unfallchirurgie, Uniklinik Köln, Köln, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH